Brussels Signal: New Media Outlet Promises to Shake Up EU Coverage
31.5.2023 11:03:00 EEST | Business Wire | Press release
Digital publisher Remedia Europe is preparing a groundbreaking news outlet, Brussels Signal , that promises to provide fresh and candid coverage of EU affairs and the issues that matter most to the citizens of Europe.
Brussels Signal will deliver rigorous reporting and analysis of the European Union. The news outlet aims to shake up the status quo by providing insightful and informed journalism that challenges prevailing ideas and policies, demands genuine accountability from decision-makers, and counters the marginalisation of dissenting voices on the issues facing Europe today.
An early version of Brussels Signal opens May 31 with an invitation to join a live event with the new editors. Other features of the news outlet – including video content and newsletters – will roll out in the coming weeks, with events coming this autumn at the Brussels Signal’s purpose-built studio in the heart of the European Quarter of Brussels.
The new media brand emerges at a time when the EU faces internal differences among Member States that are testing the work of the EU and questioning the shape and substance that European unity will take. External challenges including the war in Ukraine, energy security, migration, and trends in geopolitics are set to try the EU as a global player, and upcoming elections present opportunities for it to demonstrate its ambitions.
Meanwhile, the news industry is seeing consolidation, which means not more voices but fewer. Today’s European citizens demand greater freedom in news media, sources that raise tough questions and encourage unfettered debate; media pluralism is an essential part of this.
“We’re thrilled to introduce Brussels Signal,” said Michael Mosbacher, who played leading roles in the launch of Standpoint and The Critic in the UK and serves as Editor-in-Chief of the new media outlet. “Our team of talented journalists is dedicated to delivering accurate, timely, and insightful coverage of the most important issues affecting people throughout Europe. Our objective is to critically examine the news of the day and present a distinctive alternative viewpoint, offering a captivating source of content that engages and enlightens our audience.”
Justin Stares, a Brussels-based correspondent whose bylines have appeared in The Telegraph, Sunday Telegraph, New York Times, The Guardian, Observer, and other titles, will serve as senior editor for news. Justin is also founder of The Maritime Watch, an EU policy news service, and author of several books, most recently This is Belgium, a political, economic and social analysis of the country that hosts the EU institutions.
The site will feature regular commentary and analysis from well-known and emerging voices, including Douglas Murray, Anne-Elisabeth Moutet, Dominic Green, Kapil Komireddi, Alessandra Bocchi, William Nattrass, Ralph Schoellhammer and Felipe Fernandez-Armesto. Authored newsletters with a regional and thematic focus will highlight developments underreported in Brussels. Plus, engaging video content, including interviews with opinion leaders and podcasts.
“The EU and its Member States remain indispensable in this environment fraught with crisis and conflict, and there’s no question that European institutions and the people of Europe would benefit from a distinctive source of news and insights,” said Patrick Egan, Remedia Europe CEO and publisher of Brussels Signal. “What you see now at Brussels Signal is just the beginning. We’re ramping up our products – newsletters, podcasts and more – in our endeavour to shake up the news media landscape.
“When we look at the current media landscape, we see an opportunity. Rather than sit on the sidelines, I decided to invest my time and money to pursue that opportunity and bring about the change we need. Now we have the seed capital to finally launch with confidence in our news brand and its prospects as a sustainable business, one that will constructively influence the conversation at the European level.”
ENDS
Brussels Signal (https://brusselssignal.eu/) provides rigorous reporting on the important issues affecting citizens across Europe. Challenging the status quo with a focus on delivering insightful coverage of the issues shaping the Europe of today and tomorrow, our seasoned editors and contributors offer a distinct perspective on the news.
For more information about Brussels Signal and to read its coverage, visit www.brusselssignal.eu.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230530005558/en/
Contact information
For press inquiries
contact@brusselssignal.eu.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Estithmar Holding Pays the Third Semi-Annual coupon of the 8.75% Sukuk Tranche12.3.2026 22:50:00 EET | Press release
Estithmar Holding Q.P.S.C. has paid the third semi-annual coupon of its Qatari Riyal-denominated Sukuk (first tranche), at an annual profit rate of 8.75%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312880092/en/ Estithmar Holding Pays the Third Semi-Annual coupon of the 8.75% Sukuk Tranche (Photo: AETOSWire) The first tranche, part of the company’s broader Sukuk program valued at QAR 3.4 billion and listed on the London Stock Exchange’s International Securities Market, was issued in August 2024. The issuance attracted a diverse pool of institutional investors including banks, insurance companies, and asset managers, with strong interest from both government-affiliated and private institutions. This demand reflects growing investor confidence in Estithmar Holding’s ability to deliver sustained value to stakeholders. EstithmarHolding was recently included in the FTSE Russell Global Equity Index, in Qatar’s Mid-Cap segme
REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 202512.3.2026 16:38:00 EET | Press release
Today the Board of Directors of Reply S.p.A. [MTA, STAR: REY] approved the draft financial statement for the year 2025, which will be submitted for approval to the Shareholders’ Meeting to be held in first call in Turin on 23 April 2026. The Reply Group closed 2025 with a consolidated turnover of €2,483.6 million, an increase of 8.0% compared to €2,300.5 million in 2024. All indicators are positive for the period. Consolidated EBITDA was €467.6 million, an increase of 13.9% compared to €410.6 million at December 2024. EBIT, from January to December, was at €391.7 million, which is an increase of 18.5% compared to €330.4 million at December 2024. The Group net profit was at €250.9 million. In 2024, the corresponding value was €211.1 million. Following the results achieved in 2025, the Reply Board of Directors decided to propose to the next Shareholders’ Meeting a dividend distribution of €1.35 per share, which will be payable on 20 May 2026, with dividend date set on 18 May 2026 (record
LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market12.3.2026 15:51:00 EET | Press release
LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step for long-lasting, low-maintenance IoT products. LZE GmbH drives technology transfer to market: standard chip availability for close-to-production applications As a bridge between research and industry, LZE GmbH is making it easier for companies to access innovative technologies and helping them to quickly and reliably transform new developments into market-ready solutions. With RFicient®-IC (FH101RF), LZE is providing another high-tech product that comes directly from Fraunhofer research and can now be ordered in volume and integrated into close-to-production product development for t
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 15:30:00 EET | Press release
Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and collaborations with leading pharmaceutical companies, including MSD since 2023 for MSIntuit, Waiv is establishing itself as a leader in translational medical AI. Waiv leverages a decade of Owkin's foundational medical AI research, including access to an extensive patient data net
RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 15:30:00 EET | Press release
RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that helps sponsors gain earlier clarity, reduce risk, and execute complex programs
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
